Fondaparinux vs variable dose warfarin
Major bleeding · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes major bleeding compared with variable dose warfarin (very low certainty).
1 finding from 1 review
- Pentasaccharides for the prevention of venous thromboembolism 2016 · Cochrane Headline outcomes onlyRR 7 [0.37, 134.05]1 study · 236 participantsVery low